Immune System News and Research

RSS

New study could bring hope to men who don't respond well to hormone therapy for prostate cancer

More than 1 million American have prostate cancer, the leading non-skin cancer in men in the United States. Last year alone some 220,000 new prostate cancer cases were reported, and 28,900 men died of it.

25 Jun 2004

Mysterious disease that causes the body’s immune system to turn against itself

A mysterious disease that causes the body’s immune system to turn against itself also sends a warning signal to alert doctors of the onset of its worst symptoms, University of Florida physicians have found.

25 Jun 2004

A single dose of a test vaccine sprayed into the nose protects monkeys against the SARS virus

The study, published in the June 26 issue of the British journal The Lancet, is the third recently issued by NIAID that describes a promising candidate vaccine against SARS.

25 Jun 2004

Discovery may explain why people with AIDS may suffer severe infections from viruses that they would otherwise defeat

Researchers have uncovered the first evidence that a virus can mutate to evade the body's first line of immune defense.

25 Jun 2004

Animal vaccine shows potential for the development of human SARS immunisation

The current issue of the LANCET provides evidence for the effectiveness of experimental SARS immunisation in animal studies. The preliminary results show the potential for the development of human SARS immunisation.

24 Jun 2004

New risk factors associated with inflammatory bowel disease

Health researchers at the Christchurch School of Medicine and Health Sciences, Otago University, have found evidence of new risk factors associated with a debilitating illness called Inflammatory Bowel Disease (IBD).

24 Jun 2004

Hair cloning could be the cure for baldness

Researcher Kevin McElwee -- one of only a few people in the world who hold a doctoral degree in hair biology -- thinks a cure for baldness that uses the technique of hair cloning could be commercially available within 10 years.

24 Jun 2004

Genetic variation that doubles the risk for rheumatoid arthritis

A team of researchers has discovered a genetic variation that doubles the risk for rheumatoid arthritis (RA).

24 Jun 2004

European marketing approval for new influenza vaccine

Solvay Pharmaceuticals announced today that it has obtained European marketing approval for its new virosomal influenza vaccine: INVIVAC®.

23 Jun 2004

We want to figure out how to grow new kidneys in humans

Growing new organs to take the place of damaged or diseased ones is moving from science fiction to reality, according to researchers at Washington University School of Medicine in St. Louis.

22 Jun 2004

Cognitive decline can occur before chemotherapy treatment

In a series of studies in breast cancer patients, researchers at The University of Texas M. D. Anderson Cancer Center have confirmed the presence of “chemobrain” after chemotherapy treatment – but they also discovered that a significant portion of patients have cognitive declines even before chemotherapy.

21 Jun 2004

Fairfax student dies after a four-day hospitalization for meningitis/encephalitis

A 16-year old Chantilly high school student died last week after a four-day hospitalization for meningitis/encephalitis. The cause does not appear to be bacterial meningitis. However, an autopsy is pending and investigation is underway.

20 Jun 2004

Washington and Oregon health officials are investigating a multi-state outbreak of salmonellosis

In the past two months, more than ten people in Washington and Oregon have been infected with Salmonella after handling chicks in both states.

20 Jun 2004

First license to begin research involving therapeutic cloning

A special licensing committee of the UK Human Fertilization & Embryology Authority (HFEA) met on June 16 in London to decide whether to grant a license to scientists at The Center for Life at Newcastle University.

20 Jun 2004

Ugandans highly knowledgeable about HIV vaccine and willing to participate in future trials

A majority of Ugandan study participants are familiar with the benefits of vaccines and are willing to participate in future HIV-preventive vaccine trails

20 Jun 2004

Statins could be effective in relieving symptoms of rheumatoid arthritis

Results of a UK study in this week's issue of THE LANCET suggest that the anti-inflammatory effect of statins (a class of cholesterol-lowering drugs) could be effective in relieving symptoms of rheumatoid arthritis.

17 Jun 2004

Mothers infected with HIV who breast feed risk infecting infants

After four weeks of age, infants who breast feed from mothers infected with HIV continue to be at risk for infection with HIV for as long as they breastfeed

17 Jun 2004

Harmless virus known as GBV-C slows the progression of HIV

Iowa City Veterans Affairs (VA) Medical Center and University of Iowa (UI) researchers have unlocked part of the mystery of how a harmless virus known as GBV-C slows the progression of HIV and prolongs survival for many patients.

17 Jun 2004

New findings may help better understand how harmless viruses can cause severe disease among patients with weakened immune systems

When a major branch of the mouse immune system is disabled, a normally harmless virus can rapidly mutate into a lethal one, according to researchers at Washington University School of Medicine in St. Louis.

17 Jun 2004

Results from study of Rituxan in rheumatoid arthritis show promise

Genentech, Inc., Biogen Idec and Roche have announced that the New England Journal of Medicine published the results of a Phase IIa study showing that two doses of Rituxan® (Rituximab), administered two weeks apart, improved symptoms in patients with moderate-to-severe rheumatoid arthritis (RA) for up to 48 weeks when combined with methotrexate (MTX), compared to MTX alone.

16 Jun 2004

Immune System News and Research

New study could bring hope to men who don't respond well to hormone therapy for prostate cancer

Mysterious disease that causes the body’s immune system to turn against itself

A single dose of a test vaccine sprayed into the nose protects monkeys against the SARS virus

Discovery may explain why people with AIDS may suffer severe infections from viruses that they would otherwise defeat

Animal vaccine shows potential for the development of human SARS immunisation

New risk factors associated with inflammatory bowel disease

Hair cloning could be the cure for baldness

Genetic variation that doubles the risk for rheumatoid arthritis

European marketing approval for new influenza vaccine

We want to figure out how to grow new kidneys in humans

Cognitive decline can occur before chemotherapy treatment

Fairfax student dies after a four-day hospitalization for meningitis/encephalitis

Washington and Oregon health officials are investigating a multi-state outbreak of salmonellosis

First license to begin research involving therapeutic cloning

Ugandans highly knowledgeable about HIV vaccine and willing to participate in future trials

Statins could be effective in relieving symptoms of rheumatoid arthritis

Mothers infected with HIV who breast feed risk infecting infants

Harmless virus known as GBV-C slows the progression of HIV

New findings may help better understand how harmless viruses can cause severe disease among patients with weakened immune systems

Results from study of Rituxan in rheumatoid arthritis show promise

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News